Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredient:||Lanadelumab 150mg/mL|
|Dosage Form:||Solution for injection|
|New Zealand Sponsor:||Takeda New Zealand Limited|
|Manufacturers:||Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Catalent Indiana LLC, Indiana, United States of America
Dated this 6th day of April 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).